These three people to control stake of Ratan Tata in Tata group companies, not Maya Tata, Leah Tata, Jimmy Tata The boards of the Ratan Tata Endowment Foundation (RTEF) and the Ratan Tata ...

Tilt your stock portfolio toward biotech companies now and you could stand to make substantial profits in the near future. You can also find cost-effective stocks under $20 to trade daily on the ...

Read on for more. Biotech companies like Absci and Generate:Biomedicines have raised hundreds of millions of dollars by claiming to design novel antibody drugs from scratch using artificial ...

If these times have anything to say about it, the next Microsoft is coming from the biotech sector. Investors are moving in looking for profits, even putting companies without products on the map.

United Therapeutics is pioneering a new frontier in organ transplants using pig kidneys. A biotechnology company in Research Triangle Park has taken a major step to develop a new option for ...

Maya Mehrara is a News Reporter at Newsweek based in London, U.K.. Her focus is reporting on international news. She has covered Ukraine, Russia, immigration issues, and the revolution in Iran.

The plans are designed to extend the company's cash runway to the second half of next year. Story Feb. 6 - X4 Pharmaceuticals: The rare disease biotech is laying off 43 employees—equivalent to ...

"We are ecstatic to welcome Josh to IDEAYA as we advance our broad potential first-in-class precision medicine oncology pipeline and build a fully integrated biotechnology company. Josh is a ...

And what the heck is bio-convergence, anyway? It's where biology, engineering and artificial intelligence converge.

He pitched the synthetic biology company he had founded in a tiny basement lab in 2011, touting what he considered striking new evidence of Absci’s ability to create brand-new antibodies with ar ...

Showcase your company news with guaranteed exposure both in print and online In today's rapidly evolving business landscape, CFOs are pivotal in driving organizational success through ...

Prior, Bleharski worked as a senior staff scientist at a private biotechnology company in San Diego and was a post-doctoral fellow at the La Jolla Institute for Allergy and Immunology and the UCLA ...